Access Consortium sets 2026 priorities to accelerate work-sharing and improve patient access to innovative medicines
The heads of the regulatory authorities from Australia, Canada, Singapore, Switzerland and the UK agreed priorities to strengthen collaboration and improve regulatory efficiency at the first Access Consortium meeting of 2026 on 30 March 2026, chaired for the first time by MHRA. An action plan for 2026 was endorsed to support the GROWTH manifesto agreed […]